Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 521 – 540 of 3231

Ganciclovir (Ophthalmic)

https://clinicalinfo.hiv.gov/drugs/ganciclovir-ophthalmic/patient

Ganciclovir (Oftálmico)

https://clinicalinfo.hiv.gov/drugs/ganciclovir-ophthalmic/patient

Ganciclovir (Ophthalmic)

https://clinicalinfo.hiv.gov/drugs/ganciclovir-ophthalmic/fda-labels

Trifluridine (Ophthalmic)

https://clinicalinfo.hiv.gov/drugs/trifluridine-ophthalmic/patient

Trifluridina (Oftálmica)

https://clinicalinfo.hiv.gov/drugs/trifluridine-ophthalmic/patient

Trifluridine (Ophthalmic)

https://clinicalinfo.hiv.gov/drugs/trifluridine-ophthalmic/fda-labels

Cardiovascular Complications in People With HIV

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/cardiovascular-complications

Weight Gain in People With Treated HIV

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/weight-gain-people-treated-hiv

Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV

https://clinicalinfo.hiv.gov/news/updates-guidelines-use-antiretroviral-agents-adults-and-adolescents-hiv-6

Actualizaciones a las Guías para el Uso de Agentes Antirretrovirales en Adultos y Adolescentes con VIH

https://clinicalinfo.hiv.gov/news/updates-guidelines-use-antiretroviral-agents-adults-and-adolescents-hiv-6

Update to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection

https://clinicalinfo.hiv.gov/news/update-guidelines-use-antiretroviral-agents-pediatric-hiv-infection-1

Actualizaciones a las Guías para el uso de agentes antirretrovirales en la infección pediátrica por VIH

https://clinicalinfo.hiv.gov/news/update-guidelines-use-antiretroviral-agents-pediatric-hiv-infection-1

The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents With HIV is Accepting Applications for Scientific/Clinical Members

https://clinicalinfo.hiv.gov/news/hhs-panel-antiretroviral-guidelines-adults-and-adolescents-hiv-accepting-applications-1

Se están aceptando nominaciones de miembros científicos/ clínicos para el Panel del Departamento de Salud y Servicios Humanos (HHS) para las Guías Antirretrovirales para Adultos y Adolescentes con el VIH

https://clinicalinfo.hiv.gov/news/hhs-panel-antiretroviral-guidelines-adults-and-adolescents-hiv-accepting-applications-1

Community Member Nominations are Now Being Accepted for the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents With HIV

https://clinicalinfo.hiv.gov/news/community-member-nominations-are-now-being-accepted-hhs-panel-antiretroviral-guidelines-1

Se aceptan nominaciones de miembros de la comunidad para el panel del HHS sobre las Guías antirretrovirales para adultos y adolescentes con VIH

https://clinicalinfo.hiv.gov/news/community-member-nominations-are-now-being-accepted-hhs-panel-antiretroviral-guidelines-1

https://clinicalinfo.hiv.gov/drugs/ulonivirine/health-professional

https://clinicalinfo.hiv.gov/drugs/ulonivirine/health-professional

https://clinicalinfo.hiv.gov/drugs/ulonivirine/patient

https://clinicalinfo.hiv.gov/drugs/ulonivirine/patient